MX9100611A - Analogos de 5-amino-1-beta-d-ribofuranosilimidazol-4-carboxamida - Google Patents

Analogos de 5-amino-1-beta-d-ribofuranosilimidazol-4-carboxamida

Info

Publication number
MX9100611A
MX9100611A MX9100611A MX9100611A MX9100611A MX 9100611 A MX9100611 A MX 9100611A MX 9100611 A MX9100611 A MX 9100611A MX 9100611 A MX9100611 A MX 9100611A MX 9100611 A MX9100611 A MX 9100611A
Authority
MX
Mexico
Prior art keywords
analogs
beta
amino
ribofuranosilimidazol
carboxamida
Prior art date
Application number
MX9100611A
Other languages
English (en)
Inventor
David A Bullough
Harry E Gruber
Ernest K Metzner
Kevin M Mullane
Bheemarao G Ugarkar
Clinton E Browne
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of MX9100611A publication Critical patent/MX9100611A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
  • Electronic Switches (AREA)
  • Amplifiers (AREA)
  • Networks Using Active Elements (AREA)
  • Peptides Or Proteins (AREA)
MX9100611A 1990-08-10 1991-08-09 Analogos de 5-amino-1-beta-d-ribofuranosilimidazol-4-carboxamida MX9100611A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56619690A 1990-08-10 1990-08-10
US73218291A 1991-07-17 1991-07-17

Publications (1)

Publication Number Publication Date
MX9100611A true MX9100611A (es) 1992-04-01

Family

ID=27074101

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100611A MX9100611A (es) 1990-08-10 1991-08-09 Analogos de 5-amino-1-beta-d-ribofuranosilimidazol-4-carboxamida

Country Status (10)

Country Link
EP (1) EP0495091B1 (es)
JP (3) JP3801620B2 (es)
AT (1) ATE186837T1 (es)
AU (1) AU656737B2 (es)
CA (1) CA2067151C (es)
DE (1) DE69131796T2 (es)
IE (1) IE912833A1 (es)
IL (1) IL99124A (es)
MX (1) MX9100611A (es)
WO (1) WO1992002214A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615556B2 (ja) * 1989-11-10 1994-03-02 旭化成工業株式会社 ４―カルバモイル―１―β―Ｄ―リボフラノシル―イミダゾリウム―５―オレイト無水結晶
IL103294A0 (en) * 1991-09-30 1993-05-13 Gensia Pharma Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow
IL108523A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
JP4172095B2 (ja) 1999-06-11 2008-10-29 日本精工株式会社 トロイダル型無段変速機
JP2008534601A (ja) 2005-03-28 2008-08-28 ペリコー セラピューティクス， インコーポレイテッド 患者における副作用を予防または減少するための方法、組成物および処方物
TW200827367A (en) * 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome
WO2008086341A1 (en) * 2007-01-09 2008-07-17 Pericor Therapeutics, Inc. Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
WO2010040110A1 (en) 2008-10-03 2010-04-08 Pericor Therapeutics, Inc. Methods and compositions for treatment of acute heart failure

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1425028A (fr) * 1964-02-24 1966-01-14 Kyowa Hakko Kogyo Kk Procédé de production par fermentation de 5-amino-4-imidazole carboxamidoribotide
AT350735B (de) * 1976-08-06 1979-06-11 Hoffmann La Roche Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
US5030623A (en) * 1986-03-27 1991-07-09 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
EP0331080A3 (en) * 1988-02-29 1990-11-22 Yamasa Shoyu Kabushiki Kaisha Imidazole derivatives, process for production thereof, and use thereof
EP0427799B1 (en) * 1989-01-24 1994-11-30 Gensia, Inc. Method and compounds for aica riboside delivery and for lowering blood glucose

Also Published As

Publication number Publication date
DE69131796T2 (de) 2000-06-29
IE912833A1 (en) 1992-02-12
AU8624291A (en) 1992-03-02
EP0495091A4 (en) 1993-01-07
EP0495091A1 (en) 1992-07-22
DE69131796D1 (de) 1999-12-30
CA2067151C (en) 2004-02-03
JP2005023086A (ja) 2005-01-27
IL99124A0 (en) 1992-07-15
WO1992002214A1 (en) 1992-02-20
JP3801620B2 (ja) 2006-07-26
CA2067151A1 (en) 1992-02-11
JP2009102366A (ja) 2009-05-14
JPH05502242A (ja) 1993-04-22
ATE186837T1 (de) 1999-12-15
EP0495091B1 (en) 1999-11-24
IL99124A (en) 1998-02-22
AU656737B2 (en) 1995-02-16

Similar Documents

Publication Publication Date Title
MA22144A1 (fr) Les analogues du nucleoside de 1,3-oxathiolane .
DE3852682D1 (de) Therapeutische Nucleoside.
DE3778626D1 (de) Nukleosid-phospholipid-konjugat.
FI913236A0 (fi) 9-purinylfosfonsyraderivat.
MC1992A1 (fr) Derives de fluorocytidine
BR8806573A (pt) Vetor de levedo
LV5781B4 (lv) Arstnieciski nukleozidi
DE68924970D1 (de) Phospholipide Nucleoside.
ES2074637T3 (es) Derivados de (fosfonometoxi)metoxi purina/pirimidina antiviricos.
DE69132632D1 (de) Neue als Immunsuppressiva nützliche karbozyklische Adenosinanaloge
MX9100611A (es) Analogos de 5-amino-1-beta-d-ribofuranosilimidazol-4-carboxamida
IT8867420A0 (it) Composizione cosmetica schiumosa
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
DK630589D0 (da) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning
DE68914750D1 (de) Therapeutische Nucleoside.
PT1140937E (pt) Analogos de nucleosidos antivirais
DK626989A (da) Adenosinderivater
DK95791A (da) Nucleosidanaloge
PT876146E (pt) Analogos de nucleosidos em terapia de combinacao de infeccoes por herpes simplex
DE69014383D1 (de) Siloxankautschukzusammensetzung.
FI930265A (fi) Antikoagulantpeptider
MX9100603A (es) Analogos de aica ribosido,sustituidos con imidazol
ATE72122T1 (de) Antivirale mischungen.
DE3463657D1 (en) 2'-deoxy-3-phosphonylmethyl nucleosides and method for their preparation
GB9506644D0 (en) Preparation of nucleoside analogues